Tags: Drug.
Idraparinux sodium is an anticoagulant medication in development by Sanofi-Aventis.It has a similar chemical structure and the same method of action as fondaparinux but with an elimination half-life about five to six times longer (an increase from fondaparinux’s 17 hours to approximately 80 hours) which means that the drug should only need to be injected once a week.Sanofi discontinued the development of idraparinux sodium.
